Some new alzheimers drugs
- Donepazine, galantamine and rivastigmine can now be used in mild, as well as in moderate disease.
- Memantine can be used if someone is intolerant to or has contraindications to the other drugs and can also be used in severe disease.
- Initiation is still by specialists but follow-up can be done by others where local protocols are in place. Standard cognitive assessment tools should be used where possible for follow-up and drugs only continued if there is ongoing benefit.
